A (2nd) response fromt he Society to my rebutal re:LDN

[Guest guest]

Dear Alan,

Please understand that no one at the National MS Society wishes to

impede the treatment of people with MS in any way, and we are

certainly not in cahoots with the pharmaceutical companies. It is

our sincerest wish that every person with MS have access to safe and

effective treatments. We do not, however, conduct clinical trials,

nor are we in a position to do so. As is clearly stated on our web

site, the Society is open to considering any high quality and

relevant research protocol. We agree that there is no downside to

supporting a clinical trial of any agent that has the potential to

treat MS safely and effectively and we suggest that you

encourage/convince physicians who see benefits in their patients to

design, propose, and undertake the studies that would meet the

standards of the scientific community and of the regulatory

authorities.

lind Kalb

lind C. Kalb, Ph.D.

Director, Professional Resource Center

National Multiple Sclerosis Society

733 Third Avenue

New York, NY 10017-3288